Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Langley

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Gastroenterology|February 15, 2002
Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosisM F Yuen, S Norris, L W Evans, et al.
Gut|January 1, 1992
Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicatorsL M Pereira, P G Langley, K M Hayllar, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failureP G Langley, R Keays, R D Hughes, et al.
Journal of Hepatology|February 12, 1998
Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failureY Miwa, P M Harrison, F Farzaneh, et al.
The International Journal of Artificial Organs|December 1, 1994
Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failureR D Hughes, A Pucknell, D Routley, et al.
Hepato-Gastroenterology|August 1, 1990
Determination of the ketone body ratio in fulminant hepatic failureA Scaiola, P MacMathuna, P G Langley, et al.
European Journal of Clinical Investigation|October 1, 1986
Fibronectin replacement in patients with fulminant hepatic failureR D Hughes, M Imawari, D Bihari, et al.
The International Journal of Artificial Organs|April 1, 1996
Effect of ELAD liver support on plasma HGF and TGF-beta 1 in acute liver failureY Miwa, A J Ellis, R D Hughes, et al.
The International Journal of Artificial Organs|January 1, 1980
Platelet function during haemoperfusion in acute liver failureR D Hughes, D A Lane, G Cella, et al.
Clinical Science (London, England : 1979)|June 1, 1985
Fibrinogen derivatives and platelet activation products in acute and chronic liver diseaseR D Hughes, D A Lane, H Ireland, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Gastroenterology|February 15, 2002
Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosisM F Yuen, S Norris, L W Evans, et al.
Gut|January 1, 1992
Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicatorsL M Pereira, P G Langley, K M Hayllar, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failureP G Langley, R Keays, R D Hughes, et al.
Journal of Hepatology|February 12, 1998
Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failureY Miwa, P M Harrison, F Farzaneh, et al.
The International Journal of Artificial Organs|December 1, 1994
Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failureR D Hughes, A Pucknell, D Routley, et al.
Hepato-Gastroenterology|August 1, 1990
Determination of the ketone body ratio in fulminant hepatic failureA Scaiola, P MacMathuna, P G Langley, et al.
European Journal of Clinical Investigation|October 1, 1986
Fibronectin replacement in patients with fulminant hepatic failureR D Hughes, M Imawari, D Bihari, et al.
The International Journal of Artificial Organs|April 1, 1996
Effect of ELAD liver support on plasma HGF and TGF-beta 1 in acute liver failureY Miwa, A J Ellis, R D Hughes, et al.
The International Journal of Artificial Organs|January 1, 1980
Platelet function during haemoperfusion in acute liver failureR D Hughes, D A Lane, G Cella, et al.
Clinical Science (London, England : 1979)|June 1, 1985
Fibrinogen derivatives and platelet activation products in acute and chronic liver diseaseR D Hughes, D A Lane, H Ireland, et al.
Pageof 5